Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia

Journal of Clinical Oncology(2022)10.1200/jco.21.01900Source: DataRank Database

Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia is a research paper published in Journal of Clinical Oncology (2022). On theSindex it has a DataRank of 0.982. It has been cited 33 times, with 29 citing works in its 1-hop citation network.

N/A

0.982DataRank · unranked

Scored on demand from live citation data

Open Access33 citations · 29 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (57 grants)Impact (FWCI 1.82)OA: greenTopics (74)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 54%Citation Network 46%

Base Score Contribution

0.529

From this paper's citation signal

Citation Network Contribution

0.454

From 21 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 29 citers.

Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden
British Journal of Cancer202413 citations31 referencesContributes 0.085
The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
BMC Medicine20248 citations47 referencesContributes 0.047
Impact of analgesics on the risk of ovarian cancer; a systematic review and meta-analysis of cohort and case-control studies
Immunopathologia Persa20234 citations41 referencesContributes 0.039
Role of aspirin in cancer prevention
Cancer Treatment and Research Communications20257 citations64 referencesContributes 0.032
Highlighting the value of Alzheimer’s disease-focused registries: lessons learned from cancer surveillance
Frontiers in Aging20237 citations70 referencesContributes 0.030

Authors (33)

Mary K. Townsend ORCID,Susan J. Jordan ORCID,Alpa V. Patel ORCID,Lauren R. Teras ORCID,James V. Lacey ORCID

Live enrichment

PubMed:35867953 PMC:PMC9916035 OpenAlex:https://openalex.org/W4286602811

NCI NIH HHS

Grant: HHSN261201800032C

NCCDPHP CDC HHS

Grant: NU58DP006344

NCI NIH HHS

Grant: R01 CA039742

NCI NIH HHS

Grant: R01 CA058598

NCI NIH HHS

Grant: R01 CA076016

NCI NIH HHS

Grant: K05 CA154337

NIA NIH HHS

Grant: R01 AG061132

NCI NIH HHS

Grant: R01 CA077398

NCI NIH HHS

Grant: R03 CA113148

NCI NIH HHS

Grant: HHSN261201800009C

NCI NIH HHS

Grant: HHSN261201800015C

NCI NIH HHS

Grant: R01 CA087538

NCI NIH HHS

Grant: R01 CA095023

NCI NIH HHS

Grant: U01 CA199277

NCI NIH HHS

Grant: UM1 CA186107

NCI NIH HHS

Grant: HHSN261201800009I

NCI NIH HHS

Grant: P30 CA014089

NCI NIH HHS

Grant: P30 CA033572

NCI NIH HHS

Grant: R01 CA067262

Intramural NIH HHS

Grant: Z01 ES044005

NCI NIH HHS

Grant: N01 PC067010

NCI NIH HHS

Grant: HHSN261201800015I

NCI NIH HHS

Grant: HHSN261201800032I

NCI NIH HHS

Grant: N01 CN025403

NCI NIH HHS

Grant: P01 CA087969

NCI NIH HHS

Grant: K07 CA092044

NCI NIH HHS

Grant: P01 CA017054

NCI NIH HHS

Grant: R01 CA058860

NCI NIH HHS

Grant: UM1 CA164917

NCI NIH HHS

Grant: P30 CA023100

NCI NIH HHS

Grant: R01 CA049449

NCI NIH HHS

Grant: R01 CA112523

NCI NIH HHS

Grant: R03 CA115195

NCI NIH HHS

Grant: U01 CA176726

National Institutes of Health

Grant: 5K05CA154337-04

Established Investigator Award Anti-Inflammatory Exposures in Cancer Prevention

National Institutes of Health

Grant: N01CN055424-007

SURVEILLANCE EPIDEMIOLOGY AND END RESULTS (SEER)

National Institutes of Health

Grant: N01PC067001-001

SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM

National Institutes of Health

Grant: 5R01CA067262-08

Premenopausal Hormone Levels and Risk of Breast Cancer

National Institutes of Health

Grant: 1R01CA061132-01

CASE-CONTROL STUDY OF OVARIAN CANCER IN LOS ANGELES

National Health and Medical Research Council (NHMRC)

Grant: 400413

Australian Ovarian Cancer Study (AOCS): A multidisciplinary ovarian cancer resource for the genomic era

National Institutes of Health

Grant: 1Z01ES044005-07

Environmental and Genetic Risk Factors For Breast Cancer

National Institutes of Health

Grant: 5R01CA095023-03

Inflammation and Ovarian Cancer

National Institutes of Health

Grant: 5R01CA058860-02

HEREDITARY BREAST CANCER--GENETIC AND MOLECULAR STUDIES

National Institutes of Health

Grant: 3R01CA039742-11S1

DISTRIBUTION OF BODY FAT AND CANCER RISK IN WOMEN

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

National Institutes of Health

Grant: N01PC067010-000

SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAM

National Institutes of Health

Grant: 5R03CA115195-02

Ovarian Cancer and Gonadotropin Signaling

National Health and Medical Research Council (NHMRC)

Grant: 199600

Towards cancer control: Population and molecular strategies

National Institutes of Health

Grant: 5U01CA176726-09

Life Course Cancer Epidemiology Cohort in Women

National Institutes of Health

Grant: 5R01CA077398-09

CALIFORNIA TEACHERS STUDY

National Institutes of Health

Grant: N01CN025403-000

SURVEILLANCE EPIDEMIOLOGY AND END RESULTS

National Institutes of Health

Grant: 3U01CA199277-07S1

Genome-wide genotyping of existing samples from Asian American and Pacific Islander participants in the California Teachers Study cohort to facilitate broad and open future research

National Institutes of Health

Grant: 3P01CA087969-03S1

DIET, HORMONES AND RISK OF COLORECTAL CANCERS

National Institutes of Health

Grant: 5UM1CA164917-02

New Biospecimens to Enhance Research in the California Teachers Study Cohort

National Institutes of Health

Grant: 5UM1CA186107-05

Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study

National Institutes of Health

Grant: 5R01CA112523-03

Steroid Hormone Genes and Ovarian Cancer Risk

Cancer Research UK

FWCI

1.82

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: CC BY

repositoryhttps://discovery.ucl.ac.uk/10152789/1/jco.21.01900.pdf

repositoryhttps://discovery.ucl.ac.uk/id/eprint/10152789/

journalhttps://doi.org/10.1200/jco.21.01900

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35867953

Fields of Study

Inflammatory mediators and NSAID effectsCancer, Stress, Anesthesia, and Immune ResponseOvarian cancer diagnosis and treatment0302 clinical medicine03 medical and health sciences

MeSH Terms

AspirinEndometriosisFemaleHumansOvarian NeoplasmsRisk FactorsCase-Control Studies

Keywords

MedicineOvarian cancerAspirinOncologyRelative riskInternal medicineCancerCohort studyCase-control studyEndometriosisRisk factorLogistic regressionBreast cancerMeta-analysisGynecologyCohortConfidence intervalPrevention (rcdc)Cancer ResearchWomen's Health (rcdc)2729 Obstetrics and GynaecologyRisk Factors1103 Clinical Sciences (for)32 Biomedical and Clinical Sciences (for-2020)11 Medical and Health SciencesCancer (rcdc)Ovarian NeoplasmsHumans (mesh)Obstetrics and GynecologyGeneral Medicine1112 Oncology and Carcinogenesis (for)6.1 PharmaceuticalsFemaleOncology and CarcinogenesisClinical Sciences610Ovarian Neoplasms (mesh)Case-Control Studies (mesh)1117 Public Health and Health Services618Rare Diseases (rcdc)Rare DiseasesOvarian Cancer (rcdc)Risk Factors (mesh)3211 Oncology and carcinogenesis (for-2020)Humans1112 Oncology and CarcinogenesisObesityOncology & Carcinogenesis3.3 Nutrition and chemopreventionObesity (rcdc)6.1 Pharmaceuticals (hrcs-rac)3.3 Nutrition and chemoprevention (hrcs-rac)Biomedical and Clinical SciencesPreventionCancer (hrcs-hc)Aspirin (mesh)Oncology & Carcinogenesis (science-metrix)Female (mesh)Case-Control StudiesWomen's HealthEndometriosis (mesh)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being